Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025

Authors

• Andrew E. Aplin, Thomas Jefferson UniversityFollow
• Katherina Alsina
• Allison S. Betof
• Joseph Birkett
• Marcus O. Butler
• George Cole
• Rizwan Haq
• Florian A. Karreth
• Vinit B. Mahajan
• Rahul Marpadga
• Prithvi Mruthyunjaya
• Paul Nathan
• Jonas A. Nilsson
• Gary Palmer
• Joseph J. Sacco
• Takami Sato, Thomas Jefferson UniversityFollow
• Sarah Stanhope
• Pang-Ning Teng
• Kyleigh LiPira

Document Type

Report

Publication Date

6-23-2026

Comments

This article is the author’s final published version in Pigment Cell and Melanoma Research, Volume 39, Issue 4, 2026, Article number e70102.

The published version is available at https://doi.org/10.1111/pcmr.70102. Copyright © 2026 The Author(s).

Abstract

The 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting took place in Amsterdam, The Netherlands on October 25th, 2025. Several promising drug candidates are in development; however, there is still an urgent need for better prevention, detection, and treatment of uveal melanoma. The purpose of this meeting was to promote international collaboration and idea exchange between scientists, industry, and patient advocates.

Recommended Citation

Aplin, Andrew E.; Alsina, Katherina; Betof, Allison S.; Birkett, Joseph; Butler, Marcus O.; Cole, George; Haq, Rizwan; Karreth, Florian A.; Mahajan, Vinit B.; Marpadga, Rahul; Mruthyunjaya, Prithvi; Nathan, Paul; Nilsson, Jonas A.; Palmer, Gary; Sacco, Joseph J.; Sato, Takami; Stanhope, Sarah; Teng, Pang-Ning; and LiPira, Kyleigh, "Meeting Report From the 2025 Cure Ocular Melanoma (CURE OM) Global Science Meeting, Amsterdam, the Netherlands, October 2025" (2026). Department of Pharmacology, Physiology, and Cancer Biology Faculty Papers. Paper 68.
https://jdc.jefferson.edu/ppcbfp/68

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Language

English